Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults

References

• Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350(11):1118-29; PMID:15014185; http://dx.doi.org/10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733-45; PMID:9392700; http://dx.doi.org/10.1056/NEJM199712113372406
   PubMed Web of Science ®Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11(2):97-107; PMID:14996343; http://dx.doi.org/10.1046/j.1365-2893.2003.00487.x
   PubMed Web of Science ®Google Scholar
• Ganczak M, Szych Z, Korzen M. Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study. Vaccine 2009; 27(30):3969-74; http://dx.doi.org/10.1016/j.vaccine.2009.04.042
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34(6):1329-39; http://dx.doi.org/10.1093/ije/dyi206
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27(47):6550-7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar
• Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med 2009; 122:3-4.
   Google Scholar
• Chang MH, Hadzic D, Rouassant SH, Jonas M, Kohn IJ, Negro F, Roberts E, Sibal A; Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition. Acute and chronic hepatitis: working group report of the second world congress of pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr 2004; 39:584-8; PMID:15184756; http://dx.doi.org/10.1097/00005176-200406002-00002
   PubMed Web of Science ®Google Scholar
• Weinbaum CM, Mast EE, Ward JW. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology 2009; 49(5 Suppl):S35-44.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405-20; PMID:19817017
   PubMedGoogle Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Liu J, Gong X, Chen Y, Wang F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 2009; 200:39-47; PMID:19469708; http://dx.doi.org/10.1086/599332
   PubMed Web of Science ®Google Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Morb Mortal Wkly Rep 2007; 56(42):1114; PMID:17159833
   PubMedGoogle Scholar
• Keating GM, Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63(10):1021-51; PMID:12699402; http://dx.doi.org/10.2165/00003495-200363100-00006
   PubMed Web of Science ®Google Scholar
• Idilman R, De MN, Colantoni A, Nadir A, Van Thiel DH. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol 2002; 97(2):435-9; http://dx.doi.org/10.1111/j.1572-0241.2002.05482.x
   PubMed Web of Science ®Google Scholar
• Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991; 40(RR–13):1–25; PMID: 1835756
   Google Scholar
• American Academy of Pediatrics Committee on Infectious Diseases. Universal hepatitis B immunization. Pediatrics 1992; 89(4 Pt 2):795-800; PMID: 1557285
   PubMed Web of Science ®Google Scholar
• Daniels D, Grytdal S, Wasley A, Centers for Disease C, Prevention. Surveillance for acute viral hepatitis—United States, 2007. MMWR Surveill Summ 2009; 58(3):1-27; PMID:19478727
   PubMedGoogle Scholar
• Mast EE, Mahoney FJ, Alter MJ, Margolis HS. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine 1998; 16 Suppl:S48-51.
   PubMed Web of Science ®Google Scholar
• Levie K, Beran J, Collard F, Nguyen C. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years. Vaccine 2002; 20(19-20):2579-84; http://dx.doi.org/10.1016/S0264-410X(02)00153-6
   PubMed Web of Science ®Google Scholar
• Kollar LM, Rosenthal SL, Biro FM. Hepatitis B vaccine series compliance in adolescents. Pediatr Infect Dis J 1994; 13(11):1006-8.
   PubMed Web of Science ®Google Scholar
• Chen S. Hepatitis B vaccine immunization status and problems. World Chin J Digestol 2006; 14(27):2661-7.
   Google Scholar
• Chen S, Wang X, Dong X, Xu H, Wang F, Tang Z, Wang X, Fan J. Effects of two immunization schedules of Recombinant yeast-derived hepatitis vaccine for adults. Chin Prev Med 2013; 2(14):96-8.
   Google Scholar
• Xu F, He F, Zhou B, Zhao Q, Yan R. Observation on immunization effect of hepatitis B vaccine in adults by different dosages and schedules. Dis Surveillance 2013; 1(28):38-41.
   Google Scholar
• Belloni C, Pistorio A, Tinelli C, Komakec J, Chirico G, Rovelli D, Gulminetti R, Comolli G, Orsolini P, Rondini G. Early immunisation with hepatitis B vaccine: a five-year study. Vaccine 2000, 18(14): 1307-11.
   PubMed Web of Science ®Google Scholar
• Kulkarni PS, Raut SK, Patki PS, Phadke MA, Jadhav SS, Kapre SV, Dhorje SP, Godse SR. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults. Vaccine 2006; 24(17):3457-60; PMID:16530299; http://dx.doi.org/10.1016/j.vaccine.2006.02.008
   PubMedGoogle Scholar
• Joshi N, Kumar A, Sreenivas DV, Palan S, Nagarjuna Kumar YR. Safety and immunogenicity of indigenous recombinant hepatitis B vaccine (Shanvac-B) in comparison with commercially available vaccine. Indian J Gastroenterol 2000; 19(2):71-3; PMID:10812819
   PubMedGoogle Scholar
• Gilca V, De Serres G, Boulianne N, Murphy D, Ouakki M, De Wals P, Trudeau G, Massé R, Dionne M. Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccine. Hum Vaccin Immunother 2013; 9(8):1685-90; PMID:23744506; http://dx.doi.org/10.4161/hv.25015
   PubMed Web of Science ®Google Scholar
• Girisha KM, Kamat JR, Nataraj G. Immunological response to two hepatitis B vaccines administered in two different schedules. Indian J Pediatr 2006; 73(6):489-91; http://dx.doi.org/10.1007/BF02759892
   PubMedGoogle Scholar
• Leroux-Roels G, Haelterman E, Maes C, Levy J, De Boever F, Licini L, David MP, Dobbelaere K, Descamps D. Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine. Clin Vaccine Immunol 2011; 18(9):1510-8; PMID:21734063; http://dx.doi.org/10.1128/CVI.00539-10
   PubMedGoogle Scholar
• Hadler SC, de Monzon MA, Lugo DR, Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 1989; 7(2):106-10; http://dx.doi.org/10.1016/0264-410X(89)90046-7
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhuang GH, Wang XL, Hou TJ, Shah DP, Wei XL, Wang LR, Zhang M. Comparison of long-term immunogenicity (23 years) of 10 mug and 20 mug doses of hepatitis B vaccine in healthy children. Hum Vaccin Immunother 2012; 8(8):1071-6; http://dx.doi.org/10.4161/hv.20656
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bruden DL, Petersen KM, Bulkow LR,Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-41; PMID:15738452; http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Hurlburt D, Bulkow L, Fiore AE, Bell BP, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200:1390-6; PMID:19785526; http://dx.doi.org/10.1086/606119
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Pongpunlert W, Theamboonlers A, Vimolgej L, Chumdermpadetsuk S, Vandepapeliere P, Safary A. Randomized, single-blind comparison of the immunogenicity and reactogenicity of 20 micrograms and 10 micrograms doses of hepatitis B vaccine in adolescents. Southeast Asian J Trop Med Public Health 1993; 24(2):255-9; PMID:8266226
   PubMedGoogle Scholar
• ul-Haq N, Hasnain SS, Umar M, Abbas Z, Valenzuela-Silva C, Lopez-Saura P. Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine 2003; 21(23):3179-85; http://dx.doi.org/10.1016/S0264-410X(03)00232-9
   PubMed Web of Science ®Google Scholar
• Ren JJ, Dai XW, Jiang ZG, Shen LZ, Chen YD, Li Q, Ren W, Liu Y, Yao J, Li LJ. Immunological effects of a 10-mug dose of domestic hepatitis B vaccine in adults. J Zhejiang Univ Sci B 2012; 13(11):948-54; PMID:23125088; http://dx.doi.org/10.1631/jzus.B1200179
   PubMedGoogle Scholar
• Bennett RG, Powers DC, Remsburg RE, Scheve A, Clements ML. Hepatitis B virus vaccination for older adults. J Am Geriatr Soc 1996; 44(6):699-703; PMID:8642163
   PubMed Web of Science ®Google Scholar
• Schiff GM, Sherwood JR, Zeldis JB, Krause DS. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health 1995; 16(1):12-7; http://dx.doi.org/10.1016/1054-139X(94)00105-N
   PubMed Web of Science ®Google Scholar
• Rana SS, Singhal R, Gupta RK, Sharma D, Kar P. Immunogenicity of low-dose and conventional-dose recombinant hepatitis B vaccines in healthy adolescents in India. Singapore Med J 2004; 45(9):427-9.
   PubMedGoogle Scholar
• Velu V, Nandakumar S, Shanmugam S, Thyagarajan SP. Persistence of anti-HBs titers after two different doses of Genevac B, a recombinant hepatitis B vaccine, in healthy adolescents. Indian J Gastroenterol 2007; 26(1):48.
   PubMedGoogle Scholar
• Kim SY, Salomon JA, Goldie SJ. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves. Bull World Health Organ 2007; 85(11):833-42.
   PubMed Web of Science ®Google Scholar